共 50 条
[41]
Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9
[J].
Abraham, Jame
;
Robidoux, Andr
;
Tan, Antoinette R.
;
Limentani, Steven
;
Sturtz, Keren
;
Shalaby, Ibrahim
;
Alcorn, Hope
;
Buyse, Marc E.
;
Wolmark, Norman
;
Jacobs, Samuel A.
.
BREAST CANCER RESEARCH AND TREATMENT,
2015, 152 (02)
:399-405

Abraham, Jame
论文数: 0 引用数: 0
h-index: 0
机构:
NSABP Fdn Inc, Allegheny Ctr 2, Pittsburgh, PA 15212 USA
Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA NSABP Fdn Inc, Allegheny Ctr 2, Pittsburgh, PA 15212 USA

Robidoux, Andr
论文数: 0 引用数: 0
h-index: 0
机构:
NSABP Fdn Inc, Allegheny Ctr 2, Pittsburgh, PA 15212 USA
Ctr Hosp Univ Montreal, Montreal, PQ, Canada NSABP Fdn Inc, Allegheny Ctr 2, Pittsburgh, PA 15212 USA

Tan, Antoinette R.
论文数: 0 引用数: 0
h-index: 0
机构:
NSABP Fdn Inc, Allegheny Ctr 2, Pittsburgh, PA 15212 USA
Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
Carolinas Hlth Care Syst, Levine Canc Inst, Charlotte, NC USA NSABP Fdn Inc, Allegheny Ctr 2, Pittsburgh, PA 15212 USA

Limentani, Steven
论文数: 0 引用数: 0
h-index: 0
机构:
NSABP Fdn Inc, Allegheny Ctr 2, Pittsburgh, PA 15212 USA
Carolinas Hlth Care Syst, Levine Canc Inst, Charlotte, NC USA NSABP Fdn Inc, Allegheny Ctr 2, Pittsburgh, PA 15212 USA

Sturtz, Keren
论文数: 0 引用数: 0
h-index: 0
机构:
NSABP Fdn Inc, Allegheny Ctr 2, Pittsburgh, PA 15212 USA
CCOP Colorado Canc Res Program Inc, Denver, CO USA NSABP Fdn Inc, Allegheny Ctr 2, Pittsburgh, PA 15212 USA

Shalaby, Ibrahim
论文数: 0 引用数: 0
h-index: 0
机构:
NSABP Fdn Inc, Allegheny Ctr 2, Pittsburgh, PA 15212 USA
Joe Arrington Canc Res & Treatment Ctr, Lubbock, TX USA NSABP Fdn Inc, Allegheny Ctr 2, Pittsburgh, PA 15212 USA

Alcorn, Hope
论文数: 0 引用数: 0
h-index: 0
机构:
NSABP Fdn Inc, Allegheny Ctr 2, Pittsburgh, PA 15212 USA NSABP Fdn Inc, Allegheny Ctr 2, Pittsburgh, PA 15212 USA

Buyse, Marc E.
论文数: 0 引用数: 0
h-index: 0
机构:
IDDI, Louvain La Neuve, Belgium NSABP Fdn Inc, Allegheny Ctr 2, Pittsburgh, PA 15212 USA

Wolmark, Norman
论文数: 0 引用数: 0
h-index: 0
机构:
NSABP Fdn Inc, Allegheny Ctr 2, Pittsburgh, PA 15212 USA
Allegheny Gen Hosp, Allegheny Canc Ctr, Pittsburgh, PA 15212 USA NSABP Fdn Inc, Allegheny Ctr 2, Pittsburgh, PA 15212 USA

Jacobs, Samuel A.
论文数: 0 引用数: 0
h-index: 0
机构:
NSABP Fdn Inc, Allegheny Ctr 2, Pittsburgh, PA 15212 USA
Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA NSABP Fdn Inc, Allegheny Ctr 2, Pittsburgh, PA 15212 USA
[42]
A multicenter prospective phase II trial of neoadjuvant epirubicin, cyclophosphamide, and 5-fluorouracil (FEC100) followed by cisplatin–docetaxel with or without trastuzumab in locally advanced breast cancer
[J].
Taher AL-Tweigeri
;
Adher AlSayed
;
Shafika Alawadi
;
Mohamed Ibrahim
;
Wafaa Ashour
;
Hassan Jaafar
;
Omalkhair Abulkhair
;
Huda AL-Abdulkarim
;
Hassan Khalid
;
Dahish Ajarim
.
Cancer Chemotherapy and Pharmacology,
2016, 77
:147-153

Taher AL-Tweigeri
论文数: 0 引用数: 0
h-index: 0
机构: King Faisal Specialist Hospital and Research Centre,Oncology Centre

Adher AlSayed
论文数: 0 引用数: 0
h-index: 0
机构: King Faisal Specialist Hospital and Research Centre,Oncology Centre

Shafika Alawadi
论文数: 0 引用数: 0
h-index: 0
机构: King Faisal Specialist Hospital and Research Centre,Oncology Centre

Mohamed Ibrahim
论文数: 0 引用数: 0
h-index: 0
机构: King Faisal Specialist Hospital and Research Centre,Oncology Centre

Wafaa Ashour
论文数: 0 引用数: 0
h-index: 0
机构: King Faisal Specialist Hospital and Research Centre,Oncology Centre

Hassan Jaafar
论文数: 0 引用数: 0
h-index: 0
机构: King Faisal Specialist Hospital and Research Centre,Oncology Centre

Omalkhair Abulkhair
论文数: 0 引用数: 0
h-index: 0
机构: King Faisal Specialist Hospital and Research Centre,Oncology Centre

Huda AL-Abdulkarim
论文数: 0 引用数: 0
h-index: 0
机构: King Faisal Specialist Hospital and Research Centre,Oncology Centre

Hassan Khalid
论文数: 0 引用数: 0
h-index: 0
机构: King Faisal Specialist Hospital and Research Centre,Oncology Centre

Dahish Ajarim
论文数: 0 引用数: 0
h-index: 0
机构: King Faisal Specialist Hospital and Research Centre,Oncology Centre
[43]
Neoadjuvant docetaxel and capecitabine (TX) versus docetaxel and epirubicin (TE) for locally advanced or early her2-negative breast cancer: an open-label, randomized, multi-center, phase II Trial
[J].
Houpu Yang
;
Ling Xu
;
Shan Guan
;
Xiaopeng Hao
;
Zhicheng Ge
;
Fuzhong Tong
;
Yingming Cao
;
Peng Liu
;
Bo Zhou
;
Lin Cheng
;
Miao Liu
;
Hongjun Liu
;
Fei Xie
;
Siyuan Wang
;
Yuan Peng
;
Chaobin Wang
;
Shu Wang
.
BMC Cancer,
22

Houpu Yang
论文数: 0 引用数: 0
h-index: 0
机构: Peking University People’s Hospital Breast Center,Breast Disease Center

Ling Xu
论文数: 0 引用数: 0
h-index: 0
机构: Peking University People’s Hospital Breast Center,Breast Disease Center

Shan Guan
论文数: 0 引用数: 0
h-index: 0
机构: Peking University People’s Hospital Breast Center,Breast Disease Center

Xiaopeng Hao
论文数: 0 引用数: 0
h-index: 0
机构: Peking University People’s Hospital Breast Center,Breast Disease Center

Zhicheng Ge
论文数: 0 引用数: 0
h-index: 0
机构: Peking University People’s Hospital Breast Center,Breast Disease Center

Fuzhong Tong
论文数: 0 引用数: 0
h-index: 0
机构: Peking University People’s Hospital Breast Center,Breast Disease Center

Yingming Cao
论文数: 0 引用数: 0
h-index: 0
机构: Peking University People’s Hospital Breast Center,Breast Disease Center

Peng Liu
论文数: 0 引用数: 0
h-index: 0
机构: Peking University People’s Hospital Breast Center,Breast Disease Center

Bo Zhou
论文数: 0 引用数: 0
h-index: 0
机构: Peking University People’s Hospital Breast Center,Breast Disease Center

Lin Cheng
论文数: 0 引用数: 0
h-index: 0
机构: Peking University People’s Hospital Breast Center,Breast Disease Center

Miao Liu
论文数: 0 引用数: 0
h-index: 0
机构: Peking University People’s Hospital Breast Center,Breast Disease Center

Hongjun Liu
论文数: 0 引用数: 0
h-index: 0
机构: Peking University People’s Hospital Breast Center,Breast Disease Center

Fei Xie
论文数: 0 引用数: 0
h-index: 0
机构: Peking University People’s Hospital Breast Center,Breast Disease Center

Siyuan Wang
论文数: 0 引用数: 0
h-index: 0
机构: Peking University People’s Hospital Breast Center,Breast Disease Center

Yuan Peng
论文数: 0 引用数: 0
h-index: 0
机构: Peking University People’s Hospital Breast Center,Breast Disease Center

Chaobin Wang
论文数: 0 引用数: 0
h-index: 0
机构: Peking University People’s Hospital Breast Center,Breast Disease Center

Shu Wang
论文数: 0 引用数: 0
h-index: 0
机构: Peking University People’s Hospital Breast Center,Breast Disease Center
[44]
Neoadjuvant docetaxel and capecitabine (TX) versus docetaxel and epirubicin (TE) for locally advanced or early her2-negative breast cancer: an open-label, randomized, multi-center, phase II Trial
[J].
Yang, Houpu
;
Xu, Ling
;
Guan, Shan
;
Hao, Xiaopeng
;
Ge, Zhicheng
;
Tong, Fuzhong
;
Cao, Yingming
;
Liu, Peng
;
Zhou, Bo
;
Cheng, Lin
;
Liu, Miao
;
Liu, Hongjun
;
Xie, Fei
;
Wang, Siyuan
;
Peng, Yuan
;
Wang, Chaobin
;
Wang, Shu
.
BMC CANCER,
2022, 22 (01)

Yang, Houpu
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China

Xu, Ling
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ First Hosp, Breast Dis Ctr, Beijing, Peoples R China Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China

Guan, Shan
论文数: 0 引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Tongren Hosp, Dept Breast Ctr, Beijing, Peoples R China Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China

Hao, Xiaopeng
论文数: 0 引用数: 0
h-index: 0
机构:
Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Gen Surg, Beijing, Peoples R China Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China

Ge, Zhicheng
论文数: 0 引用数: 0
h-index: 0
机构:
Capital Med Univ, Beijing Friendship Hosp, Dept Gen Surg, Beijing, Peoples R China Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China

Tong, Fuzhong
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China

Cao, Yingming
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China

Liu, Peng
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China

Zhou, Bo
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China

Cheng, Lin
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China

Liu, Miao
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China

Liu, Hongjun
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China

Xie, Fei
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China

Wang, Siyuan
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China

Peng, Yuan
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China

Wang, Chaobin
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China

Wang, Shu
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China Peking Univ, Peoples Hosp, Breast Ctr, Beijing, Peoples R China
[45]
Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancer
[J].
Montero, A. J.
;
Diaz-Montero, C. M.
;
Deutsch, Y. E.
;
Hurley, J.
;
Koniaris, L. G.
;
Rumboldt, T.
;
Yasir, S.
;
Jorda, M.
;
Garret-Mayer, E.
;
Avisar, E.
;
Slingerland, J.
;
Silva, O.
;
Welsh, C.
;
Schuhwerk, K.
;
Seo, P.
;
Pegram, M. D.
;
Glueck, S.
.
BREAST CANCER RESEARCH AND TREATMENT,
2012, 132 (01)
:215-223

Montero, A. J.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA

Diaz-Montero, C. M.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA

Deutsch, Y. E.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA

Hurley, J.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA

Koniaris, L. G.
论文数: 0 引用数: 0
h-index: 0
机构:
Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA

Rumboldt, T.
论文数: 0 引用数: 0
h-index: 0
机构:
Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA

Yasir, S.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA

Jorda, M.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA

Garret-Mayer, E.
论文数: 0 引用数: 0
h-index: 0
机构:
Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA

Avisar, E.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA

Slingerland, J.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA

Silva, O.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA

Welsh, C.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA

Schuhwerk, K.
论文数: 0 引用数: 0
h-index: 0
机构:
Novelos Therapeut Inc, Newton, MA USA Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA

Seo, P.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA

Pegram, M. D.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA

Glueck, S.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA
[46]
PHASE-II STUDY OF HIGH-DOSE EPIRUBICIN IN COMBINATION WITH CYCLOPHOSPHAMIDE IN PATIENTS WITH ADVANCED BREAST-CANCER
[J].
LEVI, JA
;
BEITH, JM
;
SNYDER, RD
;
TATTERSALL, MH
;
BELL, D
;
WHEELER, H
.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE,
1995, 25 (05)
:474-478

LEVI, JA
论文数: 0 引用数: 0
h-index: 0
机构: ROYAL N SHORE HOSP,DEPT ONCOL,SYDNEY,NSW,AUSTRALIA

BEITH, JM
论文数: 0 引用数: 0
h-index: 0
机构: ROYAL N SHORE HOSP,DEPT ONCOL,SYDNEY,NSW,AUSTRALIA

SNYDER, RD
论文数: 0 引用数: 0
h-index: 0
机构: ROYAL N SHORE HOSP,DEPT ONCOL,SYDNEY,NSW,AUSTRALIA

TATTERSALL, MH
论文数: 0 引用数: 0
h-index: 0
机构: ROYAL N SHORE HOSP,DEPT ONCOL,SYDNEY,NSW,AUSTRALIA

BELL, D
论文数: 0 引用数: 0
h-index: 0
机构: ROYAL N SHORE HOSP,DEPT ONCOL,SYDNEY,NSW,AUSTRALIA

WHEELER, H
论文数: 0 引用数: 0
h-index: 0
机构: ROYAL N SHORE HOSP,DEPT ONCOL,SYDNEY,NSW,AUSTRALIA
[47]
Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer
[J].
Buzdar, A. U.
;
Xu, B.
;
Digumarti, R.
;
Goedhals, L.
;
Hu, X.
;
Semiglazov, V.
;
Cheporov, S.
;
Gotovkin, E.
;
Hoersch, S.
;
Rittweger, K.
;
Miles, D. W.
;
O'Shaughnessy, J.
;
Tjulandin, S.
.
ANNALS OF ONCOLOGY,
2012, 23 (03)
:589-+

Buzdar, A. U.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA

Xu, B.
论文数: 0 引用数: 0
h-index: 0
机构:
Chinese Acad Med Sci, Dept Med Oncol, Canc Inst & Hosp, Beijing 100730, Peoples R China
Peking Union Med Coll, Beijing 100021, Peoples R China Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA

Digumarti, R.
论文数: 0 引用数: 0
h-index: 0
机构:
Nizams Inst Med Sci, Dept Med Oncol, Hyderabad, Andhra Pradesh, India Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA

Goedhals, L.
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Hosp, Dept Oncotherapy, Bloemfontein, South Africa Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA

Hu, X.
论文数: 0 引用数: 0
h-index: 0
机构:
Fudan Univ, Canc Hosp, Shanghai 200433, Peoples R China Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA

Semiglazov, V.
论文数: 0 引用数: 0
h-index: 0
机构:
NN Petrov Oncol Res Inst, Breast Canc Dept, St Petersburg, Russia Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA

Cheporov, S.
论文数: 0 引用数: 0
h-index: 0
机构:
Reg Clin Oncol Hosp, Dept Oncol, Yaroslavl, Russia Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA

Gotovkin, E.
论文数: 0 引用数: 0
h-index: 0
机构:
Reg Oncol Dispensary, Dept Oncol, Ivanovo, Russia Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA

Hoersch, S.
论文数: 0 引用数: 0
h-index: 0
机构:
Dr Manfred Kohler GmbH, Dept Stat, Freiburg, Germany Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA

Rittweger, K.
论文数: 0 引用数: 0
h-index: 0
机构:
Hoffmann La Roche Inc, Prod Dev Oncol Dept, Nutley, NJ 07110 USA Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA

Miles, D. W.
论文数: 0 引用数: 0
h-index: 0
机构:
E&N Hertfordshire NHS Trust, Mt Vernon Canc Ctr, Dept Med Oncol, Northwood, Middx, England Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA

O'Shaughnessy, J.
论文数: 0 引用数: 0
h-index: 0
机构:
US Oncol, Texas Oncol, Baylor Sammons Canc, Dept Med Oncol, Dallas, TX USA Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA

Tjulandin, S.
论文数: 0 引用数: 0
h-index: 0
机构:
Blokhin Canc Res Ctr, Dept Clin Pharmacol & Chemotherapy, Moscow, Russia Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA
[48]
A multicenter prospective phase II trial of neoadjuvant epirubicin, cyclophosphamide, and 5-fluorouracil (FEC100) followed by cisplatin-docetaxel with or without trastuzumab in locally advanced breast cancer
[J].
AL-Tweigeri, Taher
;
AlSayed, Adher
;
Alawadi, Shafika
;
Ibrahim, Mohamed
;
Ashour, Wafaa
;
Jaafar, Hassan
;
Abulkhair, Omalkhair
;
AL-Abdulkarim, Huda
;
Khalid, Hassan
;
Ajarim, Dahish
.
CANCER CHEMOTHERAPY AND PHARMACOLOGY,
2016, 77 (01)
:147-153

AL-Tweigeri, Taher
论文数: 0 引用数: 0
h-index: 0
机构:
King Faisal Specialist Hosp & Res Ctr, Ctr Oncol, Riyadh 11211, Saudi Arabia King Faisal Specialist Hosp & Res Ctr, Ctr Oncol, Riyadh 11211, Saudi Arabia

AlSayed, Adher
论文数: 0 引用数: 0
h-index: 0
机构:
King Faisal Specialist Hosp & Res Ctr, Ctr Oncol, Riyadh 11211, Saudi Arabia King Faisal Specialist Hosp & Res Ctr, Ctr Oncol, Riyadh 11211, Saudi Arabia

Alawadi, Shafika
论文数: 0 引用数: 0
h-index: 0
机构:
Kuwait Univ, Fac Med, Dept Med, Kuwait, Kuwait King Faisal Specialist Hosp & Res Ctr, Ctr Oncol, Riyadh 11211, Saudi Arabia

Ibrahim, Mohamed
论文数: 0 引用数: 0
h-index: 0
机构:
Egypt Atom Energy Author, Cairo, Egypt King Faisal Specialist Hosp & Res Ctr, Ctr Oncol, Riyadh 11211, Saudi Arabia

Ashour, Wafaa
论文数: 0 引用数: 0
h-index: 0
机构:
Alminia Univ, Fac Med, Al Minya, Egypt King Faisal Specialist Hosp & Res Ctr, Ctr Oncol, Riyadh 11211, Saudi Arabia

Jaafar, Hassan
论文数: 0 引用数: 0
h-index: 0
机构:
Tawam Hosp, Al Ain, U Arab Emirates King Faisal Specialist Hosp & Res Ctr, Ctr Oncol, Riyadh 11211, Saudi Arabia

Abulkhair, Omalkhair
论文数: 0 引用数: 0
h-index: 0
机构:
Minist Natl Guard, Hlth Affairs, Riyadh, Saudi Arabia King Faisal Specialist Hosp & Res Ctr, Ctr Oncol, Riyadh 11211, Saudi Arabia

AL-Abdulkarim, Huda
论文数: 0 引用数: 0
h-index: 0
机构:
King Fahad Med City, Riyadh, Saudi Arabia King Faisal Specialist Hosp & Res Ctr, Ctr Oncol, Riyadh 11211, Saudi Arabia

Khalid, Hassan
论文数: 0 引用数: 0
h-index: 0
机构:
Al Azhar Univ, Fac Med, Cairo, Egypt King Faisal Specialist Hosp & Res Ctr, Ctr Oncol, Riyadh 11211, Saudi Arabia

Ajarim, Dahish
论文数: 0 引用数: 0
h-index: 0
机构:
King Faisal Specialist Hosp & Res Ctr, Ctr Oncol, Riyadh 11211, Saudi Arabia King Faisal Specialist Hosp & Res Ctr, Ctr Oncol, Riyadh 11211, Saudi Arabia
[49]
Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer
[J].
Mueller, Volkmar
;
Thomssen, Christoph
;
Schmidt, Marcus
;
Glados, Manfred
;
Jackisch, Christian
;
Heilmann, Volker
;
Hinke, Axel
;
Lehnert, Antje
;
Borowicz, Henryk
;
Moebus, Volker
.
BMC CANCER,
2010, 10

Mueller, Volkmar
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Med Ctr, Dept Gynecol, D-20246 Hamburg, Germany Staedt Klinikum Frankfurt Hoechst, D-65929 Frankfurt, Germany

Thomssen, Christoph
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Clin Halle Saale, Dept Gynecol & Obstet, D-06112 Halle, Saale, Germany Staedt Klinikum Frankfurt Hoechst, D-65929 Frankfurt, Germany

Schmidt, Marcus
论文数: 0 引用数: 0
h-index: 0
机构:
Johannes Gutenberg Univ Mainz, Sch Med, Univ Med Ctr, Dept Obstet & Gynecol, D-55131 Mainz, Germany Staedt Klinikum Frankfurt Hoechst, D-65929 Frankfurt, Germany

Glados, Manfred
论文数: 0 引用数: 0
h-index: 0
机构:
Onkol Schwerpunktpraxis, D-48653 Coesfeld, Germany Staedt Klinikum Frankfurt Hoechst, D-65929 Frankfurt, Germany

Jackisch, Christian
论文数: 0 引用数: 0
h-index: 0
机构:
Breast Ctr Offenbach, Clin Gynecol & Obestet, D-63069 Offenbach, Germany Staedt Klinikum Frankfurt Hoechst, D-65929 Frankfurt, Germany

Heilmann, Volker
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Clin Ulm, Dept Obstet & Gynecol, D-89075 Ulm, Germany Staedt Klinikum Frankfurt Hoechst, D-65929 Frankfurt, Germany

Hinke, Axel
论文数: 0 引用数: 0
h-index: 0
机构:
WiSP Res Inst, D-40764 Langenfeld, Germany Staedt Klinikum Frankfurt Hoechst, D-65929 Frankfurt, Germany

Lehnert, Antje
论文数: 0 引用数: 0
h-index: 0
机构:
St Josefs Hosp, Dept Gynecol, D-65189 Wiesbaden, Germany Staedt Klinikum Frankfurt Hoechst, D-65929 Frankfurt, Germany

Borowicz, Henryk
论文数: 0 引用数: 0
h-index: 0
机构:
Staedt Klinikum Frankfurt Hoechst, D-65929 Frankfurt, Germany Staedt Klinikum Frankfurt Hoechst, D-65929 Frankfurt, Germany

Moebus, Volker
论文数: 0 引用数: 0
h-index: 0
机构:
Staedt Klinikum Frankfurt Hoechst, D-65929 Frankfurt, Germany Staedt Klinikum Frankfurt Hoechst, D-65929 Frankfurt, Germany
[50]
Outcome and Cost-Effectiveness Analysis of Long-acting G-CSF as Primary Prophylaxis of Neutropenia Induced by Chemotherapy in Breast Cancer Patients, From a Retrospective Study
[J].
Wang, Yaqin
;
Zhao, Chenglong
;
Ma, Peizhi
;
Jiang, Dandan
.
CANCER CONTROL,
2023, 30

Wang, Yaqin
论文数: 0 引用数: 0
h-index: 0
机构:
Henan Univ, Zhengzhou Univ, Sch Clin Med, Dept Pharm,Henan Prov Peoples Hosp,Peoples Hosp, 7 Weiwu Rd, Zhengzhou 450001, Henan, Peoples R China Henan Univ, Zhengzhou Univ, Sch Clin Med, Dept Pharm,Henan Prov Peoples Hosp,Peoples Hosp, 7 Weiwu Rd, Zhengzhou 450001, Henan, Peoples R China

Zhao, Chenglong
论文数: 0 引用数: 0
h-index: 0
机构:
Henan Univ, Zhengzhou Univ, Sch Clin Med, Dept Pharm,Henan Prov Peoples Hosp,Peoples Hosp, 7 Weiwu Rd, Zhengzhou 450001, Henan, Peoples R China Henan Univ, Zhengzhou Univ, Sch Clin Med, Dept Pharm,Henan Prov Peoples Hosp,Peoples Hosp, 7 Weiwu Rd, Zhengzhou 450001, Henan, Peoples R China

Ma, Peizhi
论文数: 0 引用数: 0
h-index: 0
机构:
Henan Univ, Zhengzhou Univ, Sch Clin Med, Dept Pharm,Henan Prov Peoples Hosp,Peoples Hosp, 7 Weiwu Rd, Zhengzhou 450001, Henan, Peoples R China Henan Univ, Zhengzhou Univ, Sch Clin Med, Dept Pharm,Henan Prov Peoples Hosp,Peoples Hosp, 7 Weiwu Rd, Zhengzhou 450001, Henan, Peoples R China

Jiang, Dandan
论文数: 0 引用数: 0
h-index: 0
机构:
Henan Univ, Zhengzhou Univ, Sch Clin Med, Dept Pharm,Henan Prov Peoples Hosp,Peoples Hosp, 7 Weiwu Rd, Zhengzhou 450001, Henan, Peoples R China Henan Univ, Zhengzhou Univ, Sch Clin Med, Dept Pharm,Henan Prov Peoples Hosp,Peoples Hosp, 7 Weiwu Rd, Zhengzhou 450001, Henan, Peoples R China